CONMED withdraws FY2022 outlook due to warehouse software disruption; provides FY2023 guidance

CONMED Corp

Service level disruptions from new warehouse software impacted Q4 shipments; backlog peaked at $35M, now $28M.
Withdrawal of FY2022 outlook attributed solely to temporary software implementation issues.
FY2023 revenue guidance: $1.170B-$1.230B; adjusted EPS guidance: $3.20-$3.50.
Daily shipment volumes have returned to normal; backlog expected to be shipped in coming weeks.
CEO and CFO to discuss at Stifel 2022 Healthcare Conference on Nov 15, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.